Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT05543590

Effect of Plasmapheresis on Clinical Improvement and Biological Parameters of Patients With Long-haul COVID

Effect of Plasmapheresis on Clinical Improvement and Biological Parameters of Patients With Long-haul COVID: PLEXCOVIL Study, a Randomized Controlled Study.

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Hôpital Européen Marseille · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Many patients infected with SARS-Cov-2 present in the months following infection with non-specific symptoms such as non-resolving fatigue, cognitive disorders, dyspnea, headaches, myalgias, sleep disorders, anosmia/ ageusia and post exertion malaise. The persistence of these symptoms is called "post covid syndrome" or "long Covid". According to the literature, the pathophysiological mechanisms involved in post-covid syndromes would include an inadequate immune response, activation of autoimmunity, persistence of pro-inflammatory biomarkers, endothelial dysfunction and alterations in the intestinal microbiota. In view of the involved pathophysiological mechanisms, linked to the circulation of pro-inflammatory molecules, autoimmunity or endothelial activation, the role of immuno-modulation in the treatment of long Covid need to be evaluated. Plasma exchange (PE) by decreasing blood levels of pro-inflammatory cytokines and/or autoimmune markers results in moderate to marked clinical improvement in various types of autoantibody-associated inflammatory, autoimmune and neurological diseases. The goal of our study is to evaluate the effects of plasmapheresis in patients with moderate to severe long-term COVID compared to patients receiving no treatment.

Conditions

Interventions

TypeNameDescription
DRUGPlasmapheresis5 sessions of plasma exchanges
OTHERBlood collectionBlood collection to assess biological markers at baseline, M3 and M12
OTHERStool samplesStool samples will be collected from participants at baseline,M3 and M12
OTHERPET scanPET scan at baseline and M6
OTHERCycle ergometer stress testCycle ergometer stress test at M6
OTHERQuestionnaires at baselineQuestionnaires at baseline, M3 and M6
OTHERMedical consultationsMedical consultations

Timeline

Start date
2023-02-01
Primary completion
2025-02-01
Completion
2025-10-01
First posted
2022-09-16
Last updated
2023-08-14

Source: ClinicalTrials.gov record NCT05543590. Inclusion in this directory is not an endorsement.